Pfizer Inc. seeks a US Rhu/GI TA Lead to oversee the Rhu/GI portfolio, including Velsipity and Xeljanz. You will set strategy, maximize growth and patient impact while leading a team of ~15 colleagues and ~7 direct reports across brand, strategy, access and GTN.
You will own the P&L, drive end-to-end execution, partner across functions to deliver peak performance, and guide annual operating plans. This executive role requires strong leadership, strategic insight, and a track record of navigating
#J-18808-Ljbffr
This is a strong role to take on the Rheumatology & GI TA Lead — US Portfolio Growth role at 140 Pfizer Inc.
Are you ready to take on the Rheumatology & GI TA Lead — US Portfolio Growth role at 140 Pfizer Inc?
We would love to welcome a new Rheumatology & GI TA Lead — US Portfolio Growth to our group in New York, NY, United States.